Devyser acquires Swedish company Cybergene AB and strengthens its position in the aneuploidy market
Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announces that it has...
QF-PCR and maternal cell contamination by Dr Kathy Mann, the pioneer in prenatal QF-PCR analysis.
The ability to identify maternal cell contamination (MCC) in uncultured AF and CV samples minimises the risk of misdiagnosis due to the analysis of maternal cells. Authored by Dr. Kathy Manns, the pioneer in prenatal QF-PCR analysis, this paper provides information for laboratory professionals on how to identify the presence and level of MCC in a prenatal sample using a QF-PCR based approach.
QF-PCR and maternal cell contamination by Dr Kathy Mann, the pioneer in prenatal QF-PCR analysis.
The ability to identify maternal cell contamination (MCC) in uncultured AF and CV samples minimises the risk of misdiagnosis due to the analysis of maternal cells. Authored by Dr. Kathy Manns, the pioneer in prenatal QF-PCR analysis, this paper provides information for laboratory professionals on how to identify the presence and level of MCC in a prenatal sample using a QF-PCR based approach.
Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announces that it has...
Read More
Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA...
Read More
Devyser is proud to announce that the company has been awarded a tender by Oslo University Hospital...
Read More
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a new tender in...
Read More